The overall goal of the Molecular Therapeutics and Drug Discovery Program (MTDDP) is to promote interactions along the continuum of basic, preclinical, and clinical research, to develop innovative approaches to drug treatment of solid tumors and hematologic malignancies.
Specifically, the MTDDP aims to:
- identify new anticancer agents;
- understand the mechanism(s) of action of new and existing anticancer drugs; and
- optimize schedules and doses of antineoplastic drugs.
Read more about the Molecular Therapeutics and Drug Discovery Program
Research Themes:
Synthesis of chemicals or moieties that have potential anti-cancer properties
Inhibition of key cancer cell pathways as a therapeutic approach
Studies of drug uptake and metabolism, dosing, biochemical and physiological effects, and mechanisms of action
Design and performance of Phase I, Phase I/II, and Phase II studies of anti-cancer therapeutics
